Re: Grunwald et al.: Risk of Geographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2014;121:150-61)

被引：4
|
作者：
Sophie, Raafay [1 ]
Wang, Jiangxia [1 ]
Campochiaro, Peter A. [1 ]
机构：
[1] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA
来源：
OPHTHALMOLOGY | 2014年 / 121卷 / 07期
关键词：
D O I：
10.1016/j.ophtha.2013.12.043
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E34 / E34
页数：1
相关论文
共 50 条
  • [21] Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016; 123:1751-1761) (vol 124, pg e31, 2017)
    不详
    OPHTHALMOLOGY, 2017, 124 (05) : 746 - 746
  • [22] Re: Wu et al.: Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration (Ophthalmology 2014;121:2415-22) Reply
    Wu, Zhichao
    Luu, Chi D.
    Ayton, Lauren N.
    Guymer, Robyn H.
    OPHTHALMOLOGY, 2015, 122 (09) : E53 - E54
  • [23] Risk Factors for Scarring in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)
    Daniel, Ebenezer
    Toth, Cynthia
    Grunwald, Juan
    Martin, Daniel
    Ying, Gui-Shuang
    Huang, Jiayan
    Jaffe, Glenn
    Fine, Stuart
    Maguire, Maureen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [24] Emerging treatments for geographic atrophy and the impact on clinical management of age-related macular degeneration
    Abbott, Carla J.
    Guymer, Robyn H.
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2024, 107 (08) : 779 - 787
  • [25] Retinal risk factors and progression to geographic atrophy in age-related macular degeneration
    Klein, ML
    Armstrong, JR
    Hwang, TS
    Ferris, FL
    Chew, EY
    Gensler, GR
    Seddon, JM
    Bressler, SB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [26] Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials
    Zhou, Qiang
    Daniel, Ebenezer
    Maguire, Maureen G.
    Grunwald, Juan E.
    Martin, E. Revell
    Martin, Daniel F.
    Ying, Gui-shuang
    OPHTHALMOLOGY, 2016, 123 (07) : 1530 - 1540
  • [27] Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (GATT)
    Grunwald, Juan E.
    Pistilli, Maxwell
    Daniel, Ebenezer
    Ying, Gui-Shuang
    Jaffe, Glenn J.
    Fine, Stuart L.
    Martin, Daniel F.
    Maguire, Maureen G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [28] Re: Maggio et al.: Vitreomacular adhesion and the risk of neovascular age-related macular degeneration (Ophthalmology. 2017; 124: 657-666)
    Sebag, J.
    Binder, Susanne
    OPHTHALMOLOGY, 2018, 125 (01) : E6 - E6
  • [29] Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
    Jaffe, Glenn J.
    Martin, Daniel F.
    Toth, Cynthia A.
    Daniel, Ebenezer
    Maguire, Maureen G.
    Ying, Gui-Shuang
    Grunwald, Juan E.
    Huang, Jiayan
    OPHTHALMOLOGY, 2013, 120 (09) : 1860 - 1870
  • [30] Re: Yeung et al.: β-blockers and neovascular age-related macular degeneration (Ophthalmology. 2017;124:409-411)
    Kolomeyer, Anton M.
    Traband, Anastasia
    VanderBeek, Brian L.
    OPHTHALMOLOGY, 2017, 124 (09) : E70 - E71
12345